Skip to main content

Table 1 Correlation between ENTPD5 expression and clinicopathological features of serous ovarian cancer patients

From: Knockdown of ENTPD5 inhibits tumor metastasis and growth via regulating the GRP78/p-eIF-2α/CHOP pathway in serous ovarian cancer

Clinicopathological features ENTPD5 Expression level
Low High P Value
Ages(year)  < 56 13 20 0.18
 ≥ 56 7 25
FIGO stage I + II 9 5  < 0.001***
III + IV 7 44
CA125(U/ml)  < 600 11 27 0.71
 ≥ 600 9 18
Lymph node metastasis Positive 8 11 0.2
Negative 12 34
Omentum metastasis Positive 9 35  < 0.01*
Negative 11 10
  1. *p < 0.01, ***p < 0.001